MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Essential tremor(ET)"

  • 2022 International Congress

    Benefits and Risks of Staged Bilateral versus Unilateral VIM DBS for Essential Tremor

    P. Prakash, G. Deuschl, S. Ozinga, K. Mitchell, B. Cheeran, P. Larson, A. Merola, S. Groppa, T. Tomlinson, J. Ostrem (SAN FRANCISCO, USA)

    Objective: To compare the benefits and risks of staged bilateral versus unilateral VIM DBS using the largest ET DBS clinical trial dataset available to date.…
  • 2022 International Congress

    Cortical and cerebellar excitability in essential tremor

    C. Ammann, C. Pagge, JA. Pineda-Pardo, M. Del álamo, R. Martínez-Fernández, A. Oliviero, JA. Obeso, G. Foffani (Móstoles, Spain)

    Objective: To investigate the functional state of motor cortex excitability and the involvement of the cerebello-thalamo-cortical pathway using transcranial magnetic stimulation (TMS) in patients with…
  • 2022 International Congress

    Using fMRI-based multivariate pattern analysis to differentiate between hyperkinetic movement disorders

    J. Dalenberg, C. Klaver, R. Marapin, M. de Koning-Tijssen (Groningen, Netherlands)

    Objective: We aimed to investigate differences in functional magnetic resonance imaging (fMRI) brain responses across hyperkinetic movement disorders (HMDs) during a bilateral finger-tapping task.We aimed…
  • 2022 International Congress

    Preclinical Characterization of Suvecaltamide for Essential Tremor

    E. Brigham, N. Shanks, S. Markova, L. Tan, J. Kramer, D. Huffman, M. Lee (Palo Alto, USA)

    Objective: To characterize the in vitro T-type calcium (CaV3) channel target pharmacology and in vivo anti-tremor profile of suvecaltamide (JZP385, CX-8998). Background: CaV3 channels, a…
  • 2022 International Congress

    Comparison between clinical and kinematic assessment of bradykinesia

    G. Paparella, A. de Biase, L. Angelini, A. Cannavacciuolo, D. Colella, A. Guerra, D. Alunni Fegatelli, A. Berardelli, M. Bologna (Pozzilli, Italy)

    Objective: To compare the clinical and kinematic assessment of bradykinesia (movement slowness). Background: Bradykinesia may be present not only in Parkinson’s disease (PD), but also…
  • 2022 International Congress

    Network detection and connectivity analysis to predict DBS-induced ataxia in essential tremor

    B. Weigl, M. Reich (Würzburg, Germany)

    Objective: We aim to differentiate networks associated with deep brain stimulation (DBS) induced ataxia in essential tremor (ET) patients and test if connectivity to these…
  • 2022 International Congress

    Therapies, Research Funding and Racial Diversity in Essential Tremor: A Systematic Review of the Literature

    T. Zesiewicz, J. Vega, C. Gooch, S. Ghanekar, Y. Huang, Y. Bezchlibnyk, J. Staffettiij, C. Kingsbury (Tampa, USA)

    Objective: To analyze controlled clinical trials in essential tremor (ET) spanning the last 50 years in order to identify potential shortcomings in the therapeutic clinical…
  • 2022 International Congress

    Diagnosed and Drug-Treated Prevalence of Essential Tremor in Adult Patients: Retrospective Analyses of Two US Healthcare Claims Databases

    R. Saad, M. Markowitz, L. Gibbs, D. Fuller, W. Ni, R. Pahwa, K. Lyons, M. Baladi, J. Lin (Palo Alto, USA)

    Objective: Estimate the prevalence of diagnosed and drug-treated essential tremor (ET) in the adult population using 2 US healthcare claims databases. Background: ET is a…
  • 2022 International Congress

    Longitudinal study of clinical and neurophysiological features of essential tremor

    L. Angelini, A. de Biase, G. Paparella, A. Di Vita, M. Panfili, A. Maraone, R. Margiotta, A. Berardelli, M. Bologna (Rome, Italy)

    Objective: This study investigates how motor and non-motor manifestations of essential tremor (ET) progress over time. Background: ET is a common and heterogeneous movement disorder…
  • 2022 International Congress

    Clinical effectiveness and economic impact of transcutaneous afferent patterned stimulation therapy for essential tremor in a real-world setting: protocol for a pragmatic trial

    D. Dai, J. Fernandes, LA. Ramel, H. Coetzer, V. Zraick, A. Samiian, L. Hennum (Woonsocket, USA)

    Objective: To determine the feasibility of delivery, clinical effectiveness, healthcare resource utilization (HCRU) and costs of transcutaneous afferent patterned stimulation (TAPS) therapy for the treatment…
  • « Previous Page
  • 1
  • …
  • 27
  • 28
  • 29
  • 30
  • 31
  • …
  • 56
  • Next Page »

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley